CROSBY Research – Microport NeuroTech (2172 HK): A premium Chinese neuro-interventional medical device play
15 11 月, 2022研究報告
15 Nov 2022 Newly debuted on HKEX in Jul...
CROSBY Research – Channel Micron (2115 HK): Key beneficiary of China’s massive semiconductor factory buildout
9 11 月, 2022研究報告
09 Nov 2022 Channel Micron is a leading...
CROSBY Research – Precision Tsugami (China) (1651 HK/BUY): Tough 1H23 amid pandemic headwinds
9 11 月, 2022研究報告
09 Nov 2022 Following a spectacular FY22...
CROSBY Research – Crosby Bi-noculars (Bi-weekly Issue 24)
7 11 月, 2022研究報告
07 Nov 2022 Increasing investment in Chi...
CROSBY Research – TMT sector: Cleanroom facility segment, a hidden gem benefited from China’s massive semiconductor factory buildout
7 11 月, 2022研究報告
07 Nov 2022 China government strongly su...
CROSBY Research – China Suntien Green Energy (956 HK/BUY): 3Q22 revenue up 22.8% YoY
7 11 月, 2022研究報告
07 Nov 2022 Suntien reported its 3Q22 P/...
CROSBY Research – MicroPort CardioFlow (2160 HK): Innovative structural heart disease implantation specialist
7 11 月, 2022研究報告
07 Nov 2022 Listed in 2021, MicroPort Ca...
CROSBY Research – Xtep (1368 HK/BUY): Retail growth slowdown in Sept
1 11 月, 2022研究報告
01 Nov 2022 Xtep reported its 3Q22 opera...